Collegium Pharmaceutical (COLL) EPS (Diluted) Growth (3y) (2017 - 2026)
Collegium Pharmaceutical (COLL) EPS (Diluted) Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 3.25% |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 2.66% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 11.56% |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -35.09% |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 13.29% |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 36.48% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Collegium Pharmaceutical | 897.87 Mn | 748.55 Mn | 110.29 Mn | -52.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -52.23% |
| Mar 31, 2026 | 39.46% |
| Dec 31, 2025 | 58.84% |
| Sep 30, 2025 | 292.42% |
| Jun 30, 2025 | 58.85% |
| Mar 31, 2025 | 29.85% |
| Dec 31, 2024 | 35.87% |
| Sep 30, 2024 | 1.56% |
| Jun 30, 2024 | -35.30% |
| Mar 31, 2024 | 17.83% |
| Dec 31, 2023 | 56.88% |
| Sep 30, 2023 | 15.09% |
| Jun 30, 2023 | 9.75% |
| Mar 31, 2023 | -246.42% |
| Dec 31, 2022 | -47.89% |
| Sep 30, 2022 | 27.50% |
| Jun 30, 2022 | -2.66% |
| Mar 31, 2022 | -10.07% |
| Dec 31, 2021 | -61.50% |
| Sep 30, 2021 | 27.08% |